Federation Des Caisses Desjardins Du Quebec Capricor Therapeutics, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.4 Billion
- Q4 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 1,732 shares of CAPR stock, worth $19,918. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,732
Previous 2,058
15.84%
Holding current value
$19,918
Previous $31,000
25.81%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CAPR
# of Institutions
131Shares Held
15.9MCall Options Held
1.73MPut Options Held
1.71M-
Vanguard Group Inc Valley Forge, PA2.28MShares$26.2 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.25MShares$25.9 Million0.17% of portfolio
-
State Street Corp Boston, MA2.21MShares$25.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$18.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA879KShares$10.1 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $280M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...